John D. Bluth
Public Communications Contact bei BIOCRYST PHARMACEUTICALS, INC.
Aktive Positionen von John D. Bluth
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BIOCRYST PHARMACEUTICALS, INC. | Public Communications Contact | 01.04.2019 | - |
Karriereverlauf von John D. Bluth
Ehemalige bekannte Positionen von John D. Bluth
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MELINTA THERAPEUTICS, INC. | Investor Relations Kontakt | - | 31.12.2017 |
Public Communications Contact | - | 31.12.2017 | |
POWERSECURE INTERNATIONAL, INC. | Investor Relations Kontakt | 12.11.2012 | 01.01.2016 |
Public Communications Contact | 12.11.2012 | 01.01.2016 | |
Elster Group SE
Elster Group SE Industrial MachineryProducer Manufacturing Elster Group SE provided electricity, gas and water measurement and control services. The firm offered distribution monitoring and control, advanced smart metering, demand response, networking and software solutions, and related communications and services. The company was founded on October 4, 2004 and was headquartered in Mainz-Kastel, Germany. | Investor Relations Kontakt | 01.01.2009 | 01.01.2012 |
Public Communications Contact | 01.01.2009 | 01.01.2012 | |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Investor Relations Kontakt | - | 02.05.2011 |
Public Communications Contact | - | 02.05.2011 | |
Cempra, Inc.
Cempra, Inc. Pharmaceuticals: MajorHealth Technology Cempra, Inc. engages as a clinical-stage pharmaceutical company, which focuses on the development of antibacterials to meet critical medical needs. Its products include; Solithromycin and Taksta. The company was founded by Prabhavathi B. Fernandes on November 18, 2005 and is headquartered in Chapel Hill, NC. | Investor Relations Kontakt | 01.08.2016 | - |
Public Communications Contact | 01.08.2016 | - |
Ausbildung von John D. Bluth
Cornell University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 7 |
Deutschland | 2 |
Operativ
Public Communications Contact | 6 |
Investor Relations Contact | 5 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 5 |
Producer Manufacturing | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
BIOCRYST PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 5 |
---|---|
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
Elster Group SE
Elster Group SE Industrial MachineryProducer Manufacturing Elster Group SE provided electricity, gas and water measurement and control services. The firm offered distribution monitoring and control, advanced smart metering, demand response, networking and software solutions, and related communications and services. The company was founded on October 4, 2004 and was headquartered in Mainz-Kastel, Germany. | Producer Manufacturing |
PowerSecure International, Inc.
PowerSecure International, Inc. Electrical ProductsProducer Manufacturing PowerSecure International, Inc. engages in the business of providing energy technologies and services to electric utilities and large industrial, commercial, institutional and municipal customers. It provides products and services through four reporting segments: distributed generation, solar energy, utility infrastructure, and energy efficiency. The company was founded by Sidney Hinton on April 5, 1991 and is headquartered in Wake Forest, NC. | Producer Manufacturing |
Cempra, Inc.
Cempra, Inc. Pharmaceuticals: MajorHealth Technology Cempra, Inc. engages as a clinical-stage pharmaceutical company, which focuses on the development of antibacterials to meet critical medical needs. Its products include; Solithromycin and Taksta. The company was founded by Prabhavathi B. Fernandes on November 18, 2005 and is headquartered in Chapel Hill, NC. | Health Technology |
Melinta Therapeutics, Inc.
Melinta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Melinta Therapeutics, Inc. operates as a commercial-stage pharmaceutical company which engages in developing and commercializing anti-infective s for the hospital and selected non-hospital or communities. It markets antibiotics including Baxdela, Vabomere, Orbactiv, and Minocin for injections. These antibiotics are used in the treatment of infections caused by various bacterial diseases. The company was founded by William L. Jorgensen, Peter Moore, and Thomas A. Steitz in October 2000 is headquartered in Morristown, NJ. | Health Technology |
- Börse
- Insiders
- John D. Bluth
- Erfahrung